Cancer Vaccines and Methods of Treatment Using The Same
AssigneeInovio Pharmaceuticals, Inc.
InventorJian Yan
Life of this patent
Estimating the term…
Abstract
The invention provides a vaccine comprising a nucleic acid molecule that encodes a dog telomerase reverse transcriptase (dTERT) antigen, as well as methods of using the vaccine to induce an immune response against a TERT and to treat cancer in a mammal.
Claims11
A vaccine comprising a nucleic acid molecule comprising a polynucleotide sequence encoding a dog telomerase reverse transcriptase (dTERT) antigen, wherein the polynucleotide sequence is selected from the group consisting of:
- the polynucleotide sequence of SEQ ID NO:
- 4;
- a polynucleotide sequence encoding the amino acid sequence of SEQ ID NO:
- 5;
- and
- any combination thereof.
A nucleic acid molecule encoding a dog telomerase reverse transcriptase (dTERT) antigen comprising:
- the polynucleotide sequence of SEQ ID NO:4;
- or
- a polynucleotide sequence encoding the amino acid sequence of SEQ ID NO:
- 5.
A dog telomerase reverse transcriptase (dTERT) antigen comprising the amino acid sequence of SEQ ID NO:
- 5.
Dependencies are inferred from the claim text.